Fig. 2From: Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutesFlow diagram showing patient enrolment. *Registration failed because the in vivo prostate was significantly deformed relative to explanted prostate due to gas in the rectum. FCH Fluorocholine, DCFPyL 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acidBack to article page